291 related articles for article (PubMed ID: 29197112)
1. Invasion in breast lesions: the role of the epithelial-stroma barrier.
Rakha EA; Miligy IM; Gorringe KL; Toss MS; Green AR; Fox SB; Schmitt FC; Tan PH; Tse GM; Badve S; Decker T; Vincent-Salomon A; Dabbs DJ; Foschini MP; Moreno F; Wentao Y; Geyer FC; Reis-Filho JS; Pinder SE; Lakhani SR; Ellis IO
Histopathology; 2018 Jun; 72(7):1075-1083. PubMed ID: 29197112
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic study of infiltrating epitheliosis of the breast].
Xu XL; Tu XY; Shui RH; Cheng YF; Yu BH; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):827-831. PubMed ID: 29224275
[No Abstract] [Full Text] [Related]
3. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
Hilson JB; Schnitt SJ; Collins LC
Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
[TBL] [Abstract][Full Text] [Related]
4. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
[TBL] [Abstract][Full Text] [Related]
5. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
6. Detection of stromal invasion in breast cancer: the myoepithelial markers.
Yaziji H; Gown AM; Sneige N
Adv Anat Pathol; 2000 Mar; 7(2):100-9. PubMed ID: 10721417
[TBL] [Abstract][Full Text] [Related]
7. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
8. Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts.
Tait LR; Pauley RJ; Santner SJ; Heppner GH; Heng HH; Rak JW; Miller FR
Int J Cancer; 2007 May; 120(10):2127-34. PubMed ID: 17266026
[TBL] [Abstract][Full Text] [Related]
9. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
Kővári B; Báthori Á; Cserni G
Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
[TBL] [Abstract][Full Text] [Related]
10. Immunostaining patterns of myoepithelial cells in breast lesions: a comparison of CD10 and smooth muscle myosin heavy chain.
Kalof AN; Tam D; Beatty B; Cooper K
J Clin Pathol; 2004 Jun; 57(6):625-9. PubMed ID: 15166269
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
12. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells.
Raymond WA; Leong AS
Pathology; 1991 Oct; 23(4):291-7. PubMed ID: 1664512
[TBL] [Abstract][Full Text] [Related]
13. Pattern of distribution of intraductal and infiltrating ductal carcinoma: a three-dimensional study using serial coronal giant sections of the breast.
Mai KT; Yazdi HM; Burns BF; Perkins DG
Hum Pathol; 2000 Apr; 31(4):464-74. PubMed ID: 10821494
[TBL] [Abstract][Full Text] [Related]
14. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
15. Pathological criteria and practical issues in papillary lesions of the breast - a review.
Ni YB; Tse GM
Histopathology; 2016 Jan; 68(1):22-32. PubMed ID: 26768027
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
17. [Invasive carcinoma arising in breast microglandular adenosis: a clinicopathologic study of three cases and review of the literature].
Shui RH; Cheng YF; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):471-4. PubMed ID: 22088374
[TBL] [Abstract][Full Text] [Related]
18. Atypia in breast pathology: what pathologists need to know.
Katayama A; Toss MS; Parkin M; Ellis IO; Quinn C; Rakha EA
Pathology; 2022 Feb; 54(1):20-31. PubMed ID: 34872753
[TBL] [Abstract][Full Text] [Related]
19. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
Dabbs DJ; Gown AM
Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
[TBL] [Abstract][Full Text] [Related]
20. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
